The UAB Epilepsy Center at the University of Alabama at Birmingham will be conducting a study of cannabidiol, or CBD, in children and adults with severe seizure disorders that are not controlled by existing treatments. CBD is a plant-based supplement derived from the cannabis plant. It is a light, oily liquid that will be delivered orally. All those enrolled in the study will receive CBD.
If you would like to apply for the program and you live in Alabama click the link below and read all about the qualifications.
Learn more about the Research Study: Research Study Info